Additional file 5: Table S2. of Axitinib and sorafenib are potent in tyrosine kinase inhibitor resistant chronic myeloid leukemia cells
收藏Figshare2016-12-15 更新2026-04-08 收录
下载链接：
https://springernature.figshare.com/articles/dataset/Additional_file_5_Table_S2_of_Axitinib_and_sorafenib_are_potent_in_tyrosine_kinase_inhibitor_resistant_chronic_myeloid_leukemia_cells/4377485/1
下载链接
链接失效反馈官方服务：
资源简介：
Anti-GAB2 IP of Sorafenib vs DMSO treated cells. SILAC ratios are normalized to GAB2 and log2 transformed. Significant affected proteins are determined using Significance A (MaxQuant, p
提供机构：
Zehan Hu
创建时间：
2016-12-15
